Project category: Cell and Gene therapies

Development of Small Molecule Formulations for Enhanced Production of CAR-T Cell Therapies

Development of an integrated and highly intensified manufacturing process for rAAV vectors using Continuous Countercurrent Tangential Chromatography

Integrating High-Throughput Chromatography and Data Science in a Platform for the  Rapid and Accurate Quantification of Full, Partial, and Empty AAV Capsids

AAV Aggregation Testing Method Evaluation

NIIMBL’s Viral Vector: Voice of Customer Survey

Pilot Scale 50L Non-GMP AAV9 Manufacturing

A Transcriptome-Based Model for Improved CART Therapy

A Novel Perfusion-Based 3D Bioreactor for Effective Selection, Activation, and Transduction of T-Cells for Immuno-Gene Therapy

Label-Free Critical Quality Attributes of CAR T-Cell Products.

Integrated Continuous USP Platform for Maximum Productivity and Closed-Loop Controlled CQA

Gene Therapy Analytics: Inter-Laboratory Study of Orthogonal Methods to Characterize Full/Empty AAV Capsids

Developing a Fluorescence-Based Continuous (MCSGP) AEX-HPLC Method for Quantification of Full, Partial and Empty Capsid in AAV Products